Treace Medical Concepts Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, everyone. I want to thank you all for being here today. Closing out -- we're approaching the close of Wednesday at the JPMorgan Healthcare Conference. I'm really excited to be introducing some members of Treace's management team, specifically CEO, John Treace; and CFO, Mark Hair. After the prepared remarks, I'll be running a Q&A. (Operator Instructions)
And with that, John, I will leave the rest to you.
Well, good afternoon, everyone, and thanks for having us, [Alan]. We're excited at the opportunity to tell the Treace Medical story here at the 40th Annual JPMorgan Healthcare Conference. Here are standard disclosures.
So Treace Medical is a high-growth med tech company with a unique market opportunity and business strategy. First, we're the only company 100% focused on the surgical management of bunions and related pathologies. And at $5 billion plus, our U.S. market opportunity represents one of the largest in orthopedics and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
